the relationship between omega3 polyunsaturated fatty acids n3 pufa from seafood eicosapentaenoic acid epa docosahexaenoic acid dha or plant alphalinolenic acid ala sources and risk of type 2 diabetes mellitus dm remains unclearwe systematically searched multiple literature databases through june 2011 to identify prospective studies examining relations of dietary n3 pufa dietary fish andor seafood and circulating n3 pufa biomarkers with incidence of dmdata were independently extracted in duplicate by 2 investigators including multivariateadjusted relative risk rr estimates and corresponding 95 cisgeneralized leastsquares trend estimation was used to assess doseresponse relationships with pooled summary estimates calculated by both fixedeffect and randomeffect modelsfrom 288 identified abstracts 16 studies met inclusion criteria including 18 separate cohorts comprising 540184 individuals and 25670 cases of incident dmconsumption of fish andor seafood was not significantly associated with dm n13 studies rr per 100gd112 95 ci094 134 nor were consumption of epadha n16 cohorts rr per 250mgd104 95 ci097 110 or circulating levels of epadha biomarkers n5 cohorts rr per 3 of total fatty acids094 95 ci075 117both dietary ala n7 studies rr per 05gd093 95 ci083 104 and circulating ala biomarker levels n6 studies rr per 01 of total fatty acid090 95 ci080 100 p006 were associated with nonsignificant trend towards lower risk of dmsubstantial heterogeneity i280 was observed among studies of fishseafood or epadha and dm moderate heterogeneity 55 was seen for dietary and biomarker ala and dmin unadjusted metaregressions study location asia vs north americaeurope mean bmi and duration of followup each modified the association between fishseafood and epadha consumption and dm risk pinteraction  002 eachwe had limited statistical power to determine the independent effect of these sources of heterogeneity due to their high collinearitythe overall pooled findings do not support either major harms or benefits of fishseafood or epadha on development of dm and suggest that ala may be associated with modestly lower riskreasons for potential heterogeneity of effects which could include true biologic heterogeneity publication bias or chance deserve further investigation